Join us for a multi-stakeholder panel discussion following the release of the IQVIA Institute report on Drug Expenditure Dynamics 1995-2020: Understanding Medicine Spending in Context, which, for the first time, offers estimates of total drug spending, including hospitals and net of discounts and rebates across 11 countries.  The report also explains the drivers of change in drug expenditure over time and the dynamic composition by therapy area.

Topics for discussion with the panel:

  • Trends in healthcare spending and medicine spending since 1995, variability and convergence
  • Understanding the drivers of growth in drug expenditure and relative importance of newly launched drugs, pricing and volume changes over time, and post-exclusivity dynamics
  • Therapy area dynamics, contrasting high expenditure areas in 1995 with those in 2020 and the evolution over time
  • The importance of understanding medicine spending in context and relevance to current policy discussions
  • Implications of drug expenditure dynamics for stakeholders

Confirmed speakers to-date:

  • Amitabh Chandra, Ph.D., Professor of Public Policy, Director of Health Policy Research, Harvard Business School
  • Pano Kanavos, Ph.D., Deputy Director at LSE Health, London School of Economics
  • Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • David Morgan, Head of Health Accounts, The Organisation for Economic Co-operation and Development (OECD)
  • Dima Qato, Ph.D., MPH, Director, Program on Medicines and Public Health, University of Southern California


  • Welcome and introductions: Murray Aitken, Executive Director, IQVIA Institute
  • Highlights of recent research: Michael Kleinrock, Research Director, IQVIA Institute
  • Moderated discussion with panelists: Murray Aitken, Moderator
  • Audience Q&A
  • Closing

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.